PierianDx Raises $3M in New Funding, Seeks $2M More

Feb 13, 2018

|

CHICAGO (GenomeWeb) - Bioinformatics startup PierianDx has raised a little more than $3 million in new investment from unspecified sources, according to a filing with the US Securities and Exchange Commission. The total planned size of the offering is $5 million in equity and options, the St. Louis-based company disclosed this week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

High Demand

The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.

Where They Hail From

The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.

Nature Papers Describe Black Mustard Plant Genome, Link Between Autism and Dyslipidemia

In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.

All the Vaccines

According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

A Pharma’s Guide to Working with UK Biobank Data

From Synthetic Gene to Vaccine: Confidence with GeneArt Gene Synthesis Services A GenomeWeb eCase Study Transcript

Harnessing the Power of the Expi Protein Expression Systems in Vaccine Development A GenomeWeb eCase Study Transcript

Aug

19

Featured Webinar

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Aug

24

Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Sep

03

Featured Webinar

Implementation of Preemptive PGx Screening in a World-Class Personalized Medicine Program

This webinar will provide an overview of how the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado implemented a preemptive pharmacogenomic screening program via a large-scale research biobank and a robust biocomputing system.

Sep

10

Featured Webinar

Development of RNA-Based Predictive Response Signatures as Companion Diagnostics

This webinar, Part 2 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will focus on the development of RNA-based companion diagnostics for oncology.

Menu

PierianDx Raises $3M in New Funding, Seeks $2M More

To read the full story....

Breaking News

Myriad Genetics Q4 Revenues Plummet 57 Percent on Coronavirus Pandemic Pressures

Progenity Q2 Revenues Fall 70 Percent in First Earnings Report Since IPO

Bionano Genomics Q2 Revenues Fall 46 Percent

Strata, Mirati Therapeutics Partner on Tumor-Agnostic Clinical Trial of Novel KRAS G12C Inhibitor

Scipher Medicine, Galapagos Sign IBD Drug Development Deal

Triple-Negative Breast Cancer Treatment Hints Drawn From Single-Cell Study

The Scan

High Demand

Where They Hail From

Nature Papers Describe Black Mustard Plant Genome, Link Between Autism and Dyslipidemia

All the Vaccines

Featured White Papers

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

Utility of Novel RNA-Based Tools in Oncology Drug Development

Implementation of Preemptive PGx Screening in a World-Class Personalized Medicine Program

Development of RNA-Based Predictive Response Signatures as Companion Diagnostics

What's Popular?

NanoString Launches NGS Readout for Spatial Transcriptomics, Partners With Illumina on Informatics

Weill Cornell Using $1.5M NIH Grant to Predict Severity of COVID-19 Cases

Computational Tool Analyzes Noncoding Mutations to Classify Cancer Subtypes

Sponsorships